Disclosing the Preferential Mercury Chelation by SeCys Containing Peptides over Their Cys Analogues.

Methylmercury, mercury (II), and mercury (I) chlorides were found to react with vasopressin, a nonapeptide hormone cyclized by two cysteine residues, and its mono- and diselenium analogues to form several mercury-peptide adducts. The replacement of Cys by SeCys in vasopressin increased the reactivity toward methylmercury, with the predominant formation of -Se/S-Hg-Se-bridged structures and the consequent demethylation of methylmercury. In competitive experiments, CH3HgCl reacted preferentially with the diselenium analogue rather than with vasopressin. The diselenium peptide also showed the capability to displace the CH3Hg moiety bound to S in vasopressin. These results open a promising perspective for the use of selenopeptides for methylmercury chelation and detoxification strategies.

[1]  J. Szpunar,et al.  Selenol (-SeH) as a target for mercury and gold in biological systems: Contributions of mass spectrometry and atomic spectroscopy , 2022, Coordination Chemistry Reviews.

[2]  D. Lecchini,et al.  Chemical Forms of Mercury in Blue Marlin Billfish: Implications for Human Exposure , 2021, Environmental Science & Technology Letters.

[3]  Jianbo Shi,et al.  Interaction of mercury ion (Hg2+) with blood and cytotoxicity attenuation by serum albumin binding. , 2021, Journal of hazardous materials.

[4]  M. Aschner,et al.  Sulfhydryl groups as targets of mercury toxicity. , 2020, Coordination chemistry reviews.

[5]  J. Boavida,et al.  Human mercury exposure levels and fish consumption at the French Riviera. , 2020, Chemosphere.

[6]  D. Sokaras,et al.  Direct Observation of Methylmercury and Auranofin Binding to Selenocysteine in Thioredoxin Reductase. , 2020, Inorganic chemistry.

[7]  Yan Lin,et al.  Methylmercury and inorganic mercury in Chinese commercial rice: Implications for overestimated human exposure and health risk. , 2019, Environmental pollution.

[8]  C. Georgescu,et al.  Selenoproteins in human body: focus on thyroid pathophysiology , 2018, Hormones.

[9]  N. Ralston,et al.  Mercury's neurotoxicity is characterized by its disruption of selenium biochemistry. , 2018, Biochimica et biophysica acta. General subjects.

[10]  O. Proux,et al.  Mercury Trithiolate Binding (HgS3) to a de Novo Designed Cyclic Decapeptide with Three Preoriented Cysteine Side Chains. , 2018, Inorganic chemistry.

[11]  J. Feldmann,et al.  The role of selenium in mercury toxicity – Current analytical techniques and future trends in analysis of selenium and mercury interactions in biological matrices , 2017, TrAC Trends in Analytical Chemistry.

[12]  A. Casini,et al.  Mass spectrometry as a powerful tool to study therapeutic metallodrugs speciation mechanisms: Current frontiers and perspectives , 2017 .

[13]  C. Enjalbal,et al.  Investigation of Elemental Mass Spectrometry in Pharmacology for Peptide Quantitation at Femtomolar Levels , 2016, PloS one.

[14]  P. A. Nikolaychuk.  Is calomel truly a poison and what happens when it enters the human stomach? A study from the thermodynamic viewpoint , 2016 .

[15]  Chieh-Chen Huang,et al.  Structural basis of the mercury(II)-mediated conformational switching of the dual-function transcriptional regulator MerR , 2015, Nucleic acids research.

[16]  V. Peta,et al.  Functional and molecular effects of mercury compounds on the human OCTN1 cation transporter: C50 and C136 are the targets for potent inhibition. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  M. Saito,et al.  A global ocean inventory of anthropogenic mercury based on water column measurements , 2014, Nature.

[18]  M. Ngu-Schwemlein,et al.  Synthesis and ESI mass spectrometric analysis of the association of mercury(II) with multi-cysteinyl peptides. , 2014, Journal of inorganic biochemistry.

[19]  V. Peta,et al.  Inhibition of the OCTN2 carnitine transporter by HgCl2 and methylmercury in the proteoliposome experimental model: insights in the mechanism of toxicity , 2013, Toxicology mechanisms and methods.

[20]  A. Iwamatsu,et al.  S-Mercuration of rat sorbitol dehydrogenase by methylmercury causes its aggregation and the release of the zinc ion from the active site , 2012, Archives of Toxicology.

[21]  G. King,et al.  Site-specific pK(a) determination of selenocysteine residues in selenovasopressin by using 77Se NMR spectroscopy. , 2011, Angewandte Chemie.

[22]  Feiyue Wang,et al.  Chemical demethylation of methylmercury by selenoamino acids. , 2010, Chemical research in toxicology.

[23]  G. Schreckenbach,et al.  Computational studies of structural, electronic, spectroscopic, and thermodynamic properties of methylmercury-amino acid complexes and their Se analogues. , 2010, Inorganic chemistry.

[24]  Noelle E. Selin,et al.  Global Biogeochemical Cycling of Mercury: A Review , 2009 .

[25]  G. Schreckenbach,et al.  Synthesis, characterization and structures of methylmercury complexes with selenoamino acids. , 2009, Dalton transactions.

[26]  J. Szpunar,et al.  Mass spectrometry in bioinorganic analytical chemistry. , 2006, Mass spectrometry reviews.

[27]  E. Pai,et al.  NmerA, the metal binding domain of mercuric ion reductase, removes Hg2+ from proteins, delivers it to the catalytic core, and protects cells under glutathione-depleted conditions. , 2005, Biochemistry.

[28]  J. Covès,et al.  Is the cytoplasmic loop of MerT, the mercuric ion transport protein, involved in mercury transfer to the mercuric reductase? , 2004, FEBS letters.

[29]  N. Ballatori,et al.  Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. , 2002, The Biochemical journal.

[30]  R. Raines,et al.  Selenocysteine in native chemical ligation and expressed protein ligation. , 2001, Journal of the American Chemical Society.

[31]  S. Opella,et al.  Structures of the reduced and mercury-bound forms of MerP, the periplasmic protein from the bacterial mercury detoxification system. , 1997, Biochemistry.

[32]  K. Soda,et al.  Synthetic study on selenocystine-containing peptides. , 1993, Chemical & pharmaceutical bulletin.

[33]  N. Taylor,et al.  Synthesis, spectroscopic, and X-say structural characterization of methylmercury-d , l -selenocysteinate monohydrate, a key model for the methylmercury(II)-selenoprotein interaction , 1983 .

[34]  N. Taylor,et al.  Syntheses, X-ray crystal structure, and vibrational spectra of L-cysteinato(methyl)mercury(II) monohydrate , 1975 .

[35]  E. Kaiser,et al.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. , 1970, Analytical biochemistry.

[36]  Ralph G. Pearson,et al.  HARD AND SOFT ACIDS AND BASES , 1963 .

[37]  N. Loux.  An assessment of mercury-species-dependent binding with natural organic carbon , 1998 .

[38]  Y. Kajiwara,et al.  Methylmercury transport across the placenta via neutral amino acid carrier , 1996, Archives of Toxicology.

[39]  D. Pistone,et al.  A problem associated with the use of a calomel reference electrode in an ISE analytical system. , 1996, Scandinavian journal of clinical and laboratory investigation. Supplementum.